| 000 | 01530 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515184002.0 | ||
| 264 | 0 | _c20091102 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a1432-1041 | ||
| 024 | 7 |
_a10.1007/s00228-009-0719-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKefalakes, Helenie | |
| 245 | 0 | 0 |
_aExacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality? _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cOct 2009 |
||
| 300 |
_a963-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xchemically induced |
| 650 | 0 | 4 |
_aCrohn Disease _xchemically induced |
| 650 | 0 | 4 |
_aCyclooxygenase 1 _xdrug effects |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xchemically induced |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aStylianides, Theodoros J | |
| 700 | 1 | _aAmanakis, George | |
| 700 | 1 | _aKolios, George | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 65 _gno. 10 _gp. 963-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-009-0719-3 _zAvailable from publisher's website |
| 999 |
_c19112566 _d19112566 |
||